borderline significantp = 0.06
The other major change in prophylaxis has been the addition of PTCY ( 11 , 12 , 16 ) but only for patients receiving a haploidentical transplant: It is rather surprising that, despite mismatched family grafts have a higher risk of GvHD grades II–IV and III–IV, PTCY shows a borderline significant protective effect of 0.71 ( p = 0.06).